Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Siranomics begins phase-I trial of siRNA drug candidate STP707 to treat tumours

ExpressPharmaFebruary 11, 2022

Tag: STP707 , tumours , siRNA

PharmaSources Customer Service